annual CFF:
$381.23M+$294.71M(+340.66%)Summary
- As of today (May 29, 2025), SMMT annual cash flow from financing activities is $381.23 million, with the most recent change of +$294.71 million (+340.66%) on December 31, 2024.
- During the last 3 years, SMMT annual CFF has risen by +$303.31 million (+389.28%).
- SMMT annual CFF is now -38.54% below its all-time high of $620.24 million, reached on December 31, 2022.
Performance
SMMT Cash from financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFF:
$7.68M+$31.29M(+132.51%)Summary
- As of today (May 29, 2025), SMMT quarterly cash flow from financing activities is $7.68 million, with the most recent change of +$31.29 million (+132.51%) on March 31, 2025.
- Over the past year, SMMT quarterly CFF has increased by +$7.19 million (+1482.89%).
- SMMT quarterly CFF is now -98.52% below its all-time high of $520.06 million, reached on December 31, 2022.
Performance
SMMT quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFF:
$388.42M+$7.19M(+1.89%)Summary
- As of today (May 29, 2025), SMMT TTM cash flow from financing activities is $388.42 million, with the most recent change of +$7.19 million (+1.89%) on March 31, 2025.
- Over the past year, SMMT TTM CFF has increased by +$381.53 million (+5540.71%).
- SMMT TTM CFF is now -42.47% below its all-time high of $675.17 million, reached on March 31, 2023.
Performance
SMMT TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
SMMT Cash from financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +340.7% | +1482.9% | +5540.7% |
| 3 y3 years | +389.3% | -69.5% | +722.8% |
| 5 y5 years | +670.1% | +10000.0% | +10000.0% |
SMMT Cash from financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -38.5% | +389.3% | -98.5% | +132.5% | -42.5% | +5540.7% |
| 5 y | 5-year | -38.5% | +670.1% | -98.5% | +132.5% | -42.5% | >+9999.0% |
| alltime | all time | -38.5% | >+9999.0% | -98.5% | +132.5% | -42.5% | >+9999.0% |
SMMT Cash from financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $7.68M(-132.5%) | $388.42M(+1.9%) |
| Dec 2024 | $381.23M(+340.7%) | -$23.61M(-111.6%) | $381.23M(-7.3%) |
| Sep 2024 | - | $204.14M(+2.0%) | $411.09M(+98.4%) |
| Jun 2024 | - | $200.21M(>+9900.0%) | $207.18M(+2908.7%) |
| Mar 2024 | - | $485.00K(-92.2%) | $6.89M(-92.0%) |
| Dec 2023 | $86.51M(-86.1%) | $6.25M(+2630.1%) | $86.51M(-85.6%) |
| Sep 2023 | - | $229.00K(-386.3%) | $600.32M(-11.1%) |
| Jun 2023 | - | -$80.00K(-100.1%) | $675.09M(-0.0%) |
| Mar 2023 | - | $80.11M(-84.6%) | $675.17M(+8.9%) |
| Dec 2022 | $620.24M(+696.0%) | $520.06M(+593.4%) | $620.24M(+511.4%) |
| Sep 2022 | - | $75.00M(>+9900.0%) | $101.44M(+274.0%) |
| Jun 2022 | - | $0.00(-100.0%) | $27.12M(-42.5%) |
| Mar 2022 | - | $25.19M(+1897.4%) | $47.21M(-39.4%) |
| Dec 2021 | $77.92M(+54.1%) | $1.26M(+86.5%) | $77.92M(-38.7%) |
| Sep 2021 | - | $676.00K(-96.6%) | $127.20M(+0.5%) |
| Jun 2021 | - | $20.08M(-64.1%) | $126.53M(+18.9%) |
| Mar 2021 | - | $55.90M(+10.6%) | $106.44M(+110.6%) |
| Dec 2020 | $50.55M(+2.1%) | - | - |
| Dec 2020 | - | $50.55M(>+9900.0%) | $50.55M(>+9900.0%) |
| Sep 2020 | - | $0.00(0.0%) | $3000.00(-102.4%) |
| Jun 2020 | - | $0.00(-100.0%) | -$125.00K(-45.1%) |
| Mar 2020 | - | $3000.00(-102.3%) | -$227.70K(-100.9%) |
| Dec 2019 | $49.51M(+11.2%) | - | - |
| Oct 2019 | - | -$128.00K(+24.6%) | $26.37M(+2.2%) |
| Jul 2019 | - | -$102.70K(-9.8%) | $25.80M(+3.6%) |
| Apr 2019 | - | -$113.80K(-100.4%) | $24.90M(-44.0%) |
| Jan 2019 | $44.51M | - | - |
| Jan 2019 | - | $26.71M(-3909.8%) | $44.51M(+135.5%) |
| Oct 2018 | - | -$701.20K(-29.6%) | $18.90M(-50.2%) |
| Jul 2018 | - | -$995.60K(-105.1%) | $37.92M(-2.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Apr 2018 | - | $19.49M(+1670.9%) | $38.95M(+100.0%) |
| Jan 2018 | $19.47M(+3672.0%) | - | - |
| Jan 2018 | - | $1.10M(-94.0%) | $19.47M(+5.8%) |
| Oct 2017 | - | $18.33M(>+9900.0%) | $18.40M(+4676.9%) |
| Jul 2017 | - | $27.90K(+66.1%) | $385.20K(+2.3%) |
| Apr 2017 | - | $16.80K(-44.4%) | $376.70K(-27.0%) |
| Jan 2017 | $516.20K(-98.4%) | - | - |
| Jan 2017 | - | $30.20K(-90.3%) | $516.30K(-124.1%) |
| Oct 2016 | - | $310.30K(+1499.5%) | -$2.14M(-24.5%) |
| Jul 2016 | - | $19.40K(-87.6%) | -$2.83M(+24.0%) |
| Apr 2016 | - | $156.40K(-106.0%) | -$2.29M(-107.3%) |
| Jan 2016 | $31.53M(+3.4%) | - | - |
| Jan 2016 | - | -$2.63M(+585.9%) | $31.53M(-0.8%) |
| Oct 2015 | - | -$383.10K(-167.5%) | $31.77M(+5.9%) |
| Jul 2015 | - | $567.40K(-98.3%) | $30.01M(+1.5%) |
| Apr 2015 | - | $33.97M(-1524.6%) | $29.58M(-2.9%) |
| Jan 2015 | $30.48M(+314.6%) | - | - |
| Jan 2015 | - | -$2.38M(+11.5%) | $30.48M(-7.3%) |
| Oct 2014 | - | -$2.14M(-1653.3%) | $32.86M(-6.1%) |
| Jul 2014 | - | $137.70K(-99.6%) | $35.00M(+0.4%) |
| Apr 2014 | - | $34.86M | $34.86M |
| Jan 2014 | $7.35M(+2.2%) | - | - |
| Jan 2013 | $7.19M(+237.6%) | - | - |
| Jan 2012 | $2.13M(+8322.5%) | - | - |
| Jan 2011 | $25.30K(-99.7%) | - | - |
| Jan 2010 | $8.14M(+53.2%) | - | - |
| Jan 2009 | $5.31M(+298.2%) | - | - |
| Jan 2008 | $1.33M(-93.1%) | - | - |
| Jan 2007 | $19.38M(+1333.9%) | - | - |
| Jan 2006 | $1.35M(-94.9%) | - | - |
| Jan 2005 | $26.47M | - | - |
FAQ
- What is Summit Therapeutics annual cash flow from financing activities?
- What is the all time high annual CFF for Summit Therapeutics?
- What is Summit Therapeutics annual CFF year-on-year change?
- What is Summit Therapeutics quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Summit Therapeutics?
- What is Summit Therapeutics quarterly CFF year-on-year change?
- What is Summit Therapeutics TTM cash flow from financing activities?
- What is the all time high TTM CFF for Summit Therapeutics?
- What is Summit Therapeutics TTM CFF year-on-year change?
What is Summit Therapeutics annual cash flow from financing activities?
The current annual CFF of SMMT is $381.23M
What is the all time high annual CFF for Summit Therapeutics?
Summit Therapeutics all-time high annual cash flow from financing activities is $620.24M
What is Summit Therapeutics annual CFF year-on-year change?
Over the past year, SMMT annual cash flow from financing activities has changed by +$294.71M (+340.66%)
What is Summit Therapeutics quarterly cash flow from financing activities?
The current quarterly CFF of SMMT is $7.68M
What is the all time high quarterly CFF for Summit Therapeutics?
Summit Therapeutics all-time high quarterly cash flow from financing activities is $520.06M
What is Summit Therapeutics quarterly CFF year-on-year change?
Over the past year, SMMT quarterly cash flow from financing activities has changed by +$7.19M (+1482.89%)
What is Summit Therapeutics TTM cash flow from financing activities?
The current TTM CFF of SMMT is $388.42M
What is the all time high TTM CFF for Summit Therapeutics?
Summit Therapeutics all-time high TTM cash flow from financing activities is $675.17M
What is Summit Therapeutics TTM CFF year-on-year change?
Over the past year, SMMT TTM cash flow from financing activities has changed by +$381.53M (+5540.71%)